Principal Investigators

    David GRABLI

    Institution

    APHP Paris

    Contact information of lead PI

    Country

    France

    Title of project or programme

    Dénervation dopaminergique et polymorphisme de la COMT chez les patients parkinsoniens de novo. Plasma tau protein and biomarkers of amyloid precursor protein (APP) for the diagnosis and prognosis of Alzheimer's disease. Ancillary study under study BALTAZAR (Biomarker of AmyLoïd pepTide and AlZheimer's diseAse Risk).

    Source of funding information

    DGOS

    Total sum awarded (Euro)

    € 197,000

    Start date of award

    xx/xx/2013

    Total duration of award in years

    3

    Keywords

    Research Abstract

    Further information available at:

Types: Investments < €500k
Member States: France
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF